XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Understand how using tax lots for Dividend Etf losses can create precise tax benefits and align with your overall investment plan.
16,880 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Bitcoin faced a key test near $74,000 as geopolitical tensions intensified, and BlackRock launched its ETHB ETF, resh...
Bitcoin jumped to an intraday high near $82,000 on Thursday after a Senate committee advanced the Clarity Act, then e...
A cybersecurity-focused ETF bearing the infamous ticker SPAM is delivering strong 2026 gains, tripling the S&P 500's ...
A diversified cybersecurity ETF now holds CrowdStrike alongside 30 other rivals, offering broad exposure as AI-driven...
A dedicated pure-miner uranium fund has jumped 61% this year, outpacing broader uranium plays. Analysts say the move ...
AI-driven projections point to XRP testing the $3.50 level as Bitcoin steadies. ETF inflows, Ripple's institutional p...
Bitcoin surged to the $74,000 level, then reversed as selling pressure emerged near resistance. Traders are watching ...
Bitcoin fell to a two-week low as leveraged bets were wiped out and risk appetite faded amid geopolitical tensions an...
Schg’s 32× start melt-up is shaping a pivotal market moment: can a growth-heavy ETF sustain gains on high valuations,...
The relationship between OpenAI and Microsoft once looked like a straightforward path to AI profits. Today, smart mon...
Two flagship crypto ETFs from BlackRock pit Ethereum’s usage thesis against Bitcoin’s scarcity thesis. Here’s how IBI...